Eliot Forster - 29 Jul 2022 Form 4 Insider Report for F-star Therapeutics, Inc.

Role
President and CEO, Director
Signature
/s/ Darlene Deptula-Hicks, Attorney-in-fact
Issuer symbol
N/A
Transactions as of
29 Jul 2022
Net transactions value
+$28,707
Form type
4
Filing time
02 Aug 2022, 21:08:21 UTC
Previous filing
04 Apr 2022
Next filing
09 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FSTX Common Stock Options Exercise $28,707 +260,977 +163% $0.1100* 421,537 29 Jul 2022 Direct F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FSTX Stock Option (right to buy) Options Exercise $0 -32,602 -100% $0.000000* 0 29 Jul 2022 Common Stock 32,602 $0.1100 Direct F2, F4
transaction FSTX Stock Option (right to buy) Options Exercise $0 -228,375 -100% $0.000000* 0 29 Jul 2022 Common Stock 228,375 $0.1100 Direct F2, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Report is reporting the exempt exercise of employee stock options for cash payment thereof and receipt of the resulting shares. No shares were sold incidental to the exercise of these stock options.
F2 This exercise price was originally reported incorrectly as $0.08 per share due to a conversion rate error from Pound Sterling into U.S. Dollars. Using the August 2022 approximate exchange rate of 1.2211, the exercise price in U.S. Dollars would be approximately $0.11 per share.
F3 Includes 142,000 RSUs previously reported. Each RSU represents a contingent right to receive one share of the Issuer's common stock.
F4 So long as Participant remains continuously a Service Provider 28% of the total number of Shares under Award shall vest on the first anniversary of the Vesting Commencement Date, October 1, 2018, and 2% of the total number of Shares under Award shall vest monthly thereafter.
F5 Twenty-five per cent (25%) of the total number of Shares under Award shall vest on the first anniversary of the Vesting Commencement Date, July 1, 2020, and two and one twelfth per cent (2.083%) of the total number of Shares under Award shall vest monthly thereafter, provided in each case that the Participant remains a Service Provider continuously from the Vesting Commencement Date to the relevant date.